Roche Holding (RHHBY) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, ₣ | ? | 21 697 000 000 | 23 076 000 000 | 22 862 000 000 | 20 861 000 000 | 18 540 000 000 | 21 016 000 000 | ||
Changes by years, y/y, % | +19% | +6% | -1% | -9% | -11% | +0.4% |
Roche Holding. EBITDA US GAAP, ₣
Roche Holding. EBITDA US GAAP, changes, %
Roche Holding. EBITDA US GAAP, sum by quarters, ₣
Roche Holding (RHHBY) EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EBITDA, ₣ | ? | 6 108 000 000 | 4 338 500 000 | 4 338 500 000 | 6 169 500 000 | 6 169 500 000 | 21 016 000 000 | |
Changes by years, y/y, % | -20% | -56% | +1% | +1% | ||||
Changes by quarters, q/q, % | 0% | -29% | 0% | +42% | 0% |